Women’s health remains a big area of unmet medical need and since women make up half the population, the commercial opportunity is enormous, but investment in therapeutics for women – whether for female-specific conditions like endometriosis and menopause or broader areas of health – continues to be underwhelming.
Momentum In Women’s Health, But Big Obstacles Too
Unmet Need In Space Was A Theme At J.P. Morgan
Despite a big market opportunity with an underserved patient population, investment in the therapeutic area lags and investor perception is a pressure point.
